Bahl & Gaynor Inc Organon & Co. Transaction History

Bahl & Gaynor Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $210,318 - $271,859	-6,907 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $964,086 - $1.25 Million	-33,627 Reduced 82.96%	6,907 $210,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $2.07 Million - $2.58 Million	-72,440 Reduced 64.12%	40,534 $1.33 Million
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $3.21 Million - $4.29 Million	112,974 New	112,974 $3.42 Million

795

191M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.88B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

Stay updated on Bahl & Gaynor Inc with notifications on news.